Liu, Q. et al. The association between diabetes mellitus and the risk of latent tuberculosis infection: a systematic review and meta-analysis. Front. Med. 9, 899821 (2022).
Al-Rifai, R. H., Pearson, F., Critchley, J. A. & Abu-Raddad, L. J. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS ONE 12(11), e0187967 (2017).
Huangfu, P., Ugarte-Gil, C., Golub, J., Pearson, F. & Critchley, J. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. Int. J. Tuberculosis Lung Dis. 23(7), 783–796 (2019).
Chen, H. et al. The impact of pulmonary tuberculosis on immunological and metabolic features of diabetic patients. Front. Immunol. 13, 973991 (2022).
Rissaadah, S., Nursiswati, N. & Pahria, T. Glycemic profile and clinical treatment in patients with diabetes mellitus-tuberculosis: an update scoping review. J. Multidiscip. Healthc. 18, 747–758 (2025).
Hensel, R. L. et al. Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus. Int. J. Tuberc. Lung Dis. 20(1), 71–78 (2016).
Ssekamatte, P., Sande, O. J., van Crevel, R. & Biraro, I. A. Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility. Front. Immunol. 14, 1122255 (2023).
Kumar, N. P. et al. Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines. Ann. Am. Thorac. Soc. 10(5), 441–449 (2013).
Kumar, N. P. et al. Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection. J. Infect. Dis. 210(10), 1670–1678 (2014).
Domingo-Gonzalez, R., Prince, O., Cooper, A. & Khader, S. A. Cytokines and Chemokines in Mycobacterium tuberculosis Infection. Microbiol. Spectrum. 4(5), 23 (2016).
Ashenafi, S. et al. Progression of clinical tuberculosis is associated with a Th2 immune response signature in combination with elevated levels of SOCS3. Clin. Immunol. 151(2), 84–99 (2014).
Ssekamatte, P. et al. Type 2 diabetes mellitus and latent tuberculosis infection moderately influence innate lymphoid cell immune responses in Uganda. Front. Immunol. 12, 3551 (2021).
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e7-e (2015).
Wickham, H. ggplot2: Elegant Graphics for Data Analysis 2nd edn. (Springer, 2016).
Hu, R., Xia, C.-Q., Butfiloski, E. & Clare-Salzler, M. Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection. Clin. Immunol. 195, 139–148 (2018).
Grossmann, V. et al. Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes. Diabetes Care 38(7), 1356–1364 (2015).
Eckold, C. et al. Impact of intermediate hyperglycemia and diabetes on immune dysfunction in tuberculosis. Clin. Infect. Dis. 72(1), 69–78 (2020).
Maciag, K., Plumlee, C. R., Cohen, S. B., Gern, B. H. & Urdahl, K. B. Reappraising the role of T cell-derived IFN-γ in restriction of mycobacterium tuberculosis in the murine lung. J. Immunol. 213(3), 339–346 (2024).
Green, A. M., DiFazio, R. & Flynn, J. L. IFN-γ from CD4 T Cells Is essential for host survival and enhances CD8 T cell function during mycobacterium tuberculosis infection. J. Immunol. 190(1), 270–277 (2013).
Allie, N. et al. Prominent role for T cell-derived tumour necrosis factor for sustained control of mycobacterium tuberculosis infection. Sci. Rep. 3(1), 1809 (2013).
Clay, H., Volkman, H. E. & Ramakrishnan, L. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29(2), 283–294 (2008).
Liu, X. et al. IL-2 restores T-cell dysfunction induced by persistent mycobacterium tuberculosis antigen stimulation. Front. Immunol. 10, 2350 (2019).
Cooper, A. M., Magram, J., Ferrante, J. & Orme, I. M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J. Exp. Med. 186(1), 39–45 (1997).
Chen, Y.-Y. et al. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis. J. Microbiol. Immunol. Infect. 50(1), 90–96 (2017).
Roca, F. J., Whitworth, L. J., Redmond, S., Jones, A. A. & Ramakrishnan, L. TNF induces pathogenic programmed macrophage necrosis in tuberculosis through a mitochondrial-lysosomal-endoplasmic reticulum circuit. Cell 178(6), 1344–61.e11 (2019).
Blauenfeldt, T. et al. Interplay of DDP4 and IP-10 as a potential mechanism for cell recruitment to tuberculosis lesions. Front. Immunol. 9, 1456 (2018).
Taub, D. D., Turcovski-Corrales, S. M., Key, M. L., Longo, D. L. & Murphy, W. J. Chemokines and T lymphocyte activation: Beta chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156(6), 2095–2103 (1996).
Karpus, W. J. et al. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158(9), 4129–4136 (1997).
Saukkonen, J. J. et al. β-chemokines are induced by mycobacterium tuberculosis and inhibit its growth. Infect. Immun. 70(4), 1684–1693 (2002).
McNab, F. W. et al. Type I IFN Induces IL-10 production in an IL-27–independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in mycobacterium tuberculosis–infected macrophages. J. Immunol. 193(7), 3600–3612 (2014).
Kotov, D. I. et al. Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis. Cell 186(25), 5536–53.e22 (2023).
Permanyer, M. et al. Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool. Cell. Mol. Immunol. 18(2), 398–414 (2021).
Ristić-Djurović, J. L., Ćirković, S., Mladenović, P., Romčević, N. & Trbovich, A. M. Analysis of methods commonly used in biomedicine for treatment versus control comparison of very small samples. Comput. Methods Programs Biomed. 157, 153–162 (2018).
Redford, P. S., Murray, P. J. & O’Garra, A. The role of IL-10 in immune regulation during M tuberculosis infection. Mucosal Immunol. 4(3), 261–270 (2011).
Mishra, A. et al. Human macrophages exhibit GM-CSF dependent restriction of mycobacterium tuberculosis infection via regulating their self-survival. Diff. Metab. Front. Immunol. 13, 859116 (2022).
Fremond, C. M. et al. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to mycobacterium tuberculosis infection. J. Immunol. 179(2), 1178–1189 (2007).
Mayer-Barber, K. D. et al. Cutting edge: Caspase-1 Independent IL-1β Production Is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184(7), 3326–3330 (2010).
Moreira-Teixeira, L. et al. T cell-derived IL-10 impairs host resistance to mycobacterium tuberculosis infection. J. Immunol. 199(2), 613–623 (2017).
Park, H.-S. et al. Mycobacterium tuberculosis Rv2145c promotes intracellular survival by STAT3 and IL-10 receptor signaling. Front. Immunol. 12, 666293 (2021).
Sinha, R. et al. Pre-diabetes increases tuberculosis disease severity, while high body fat without impaired glucose tolerance is protective. Front. Cell. Infect. Microbiol. 11, 691823 (2021).
Tan, K. S. et al. Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J. Clin. Invest. 122(6), 2289–2300 (2012).
Restrepo, B. I. et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin. Infect. Dis. 47(5), 634–641 (2008).
Pooran, A. et al. IL-4 subverts mycobacterial containment in Mycobacterium tuberculosis-infected human macrophages. Eur. Respir. J. 54(2), 1802242 (2019).
Krupa, A. et al. Binding of CXCL8/IL-8 to Mycobacterium tuberculosis modulates the innate immune response. Mediators inflamm. 1, 124762 (2015).
Amersfoort, J. et al. Diet-induced dyslipidemia induces metabolic and migratory adaptations in regulatory T cells. Cardiovasc. Res. 117(5), 1309–1324 (2020).
Varshney, P., Yadav, V. & Saini, N. Lipid rafts in immune signalling: current progress and future perspective. Immunology 149(1), 13–24 (2016).
Legler, D. F., Micheau, O., Doucey, M.-A., Tschopp, J. & Bron, C. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFα-Mediated NF-κB activation. Immunity 18(5), 655–664 (2003).
Sen, S., Roy, K., Mukherjee, S., Mukhopadhyay, R. & Roy, S. Restoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani Infected Macrophages: role of membrane cholesterol. PLoS Pathog. 7(9), e1002229 (2011).
Ross, S. H. & Cantrell, D. A. Signaling and function of Interleukin-2 in T lymphocytes. Ann. Rev. Immunol. 36, 411–433 (2018).
Bensussen, A., Santana, M. A. & Rodríguez-Jorge, O. Metabolic alterations impair differentiation and effector functions of CD8+ T cells. Front Immunol. 13, 945980 (2022).
Mahammad, S., Dinic, J., Adler, J. & Parmryd, I. 2010 Limited cholesterol depletion causes aggregation of plasma membrane lipid rafts inducing T cell activation Biochimica et Biophysica Acta (BBA). Mol. Cell Biol. Lipids. 6, 625–634 (1801).
Zhu, Y. et al. lowering Glycosphingolipid levels in CD4+ T cells attenuates T cell receptor signaling, cytokine production, and differentiation to the Th17 lineage. J. Biol. Chem. 286(17), 14787–14794 (2011).
Lokpo, S. Y. et al. The pattern of dyslipidaemia and factors associated with elevated levels of non-HDL-cholesterol among patients with type 2 diabetes mellitus in the Ho municipality: A cross sectional study. Heliyon. 8, 8 (2022).
Abdissa, D. & Hirpa, D. Dyslipidemia and its associated factors among adult diabetes outpatients in West Shewa zone public hospitals, Ethiopia. BMC Cardiovasc. Disord. 22(1), 39 (2022).
Brake, J. et al. Inflammation and dyslipidaemia in combined diabetes and tuberculosis; a cohort study. iScience. 28, 112760 (2025).
